Annabeth P. Groenman
Annabeth P. Groenman
Unknown affiliation
Verified email at uva.nl
Title
Cited by
Cited by
Year
Substance use disorders in adolescents with attention deficit hyperactivity disorder: A 4‐year follow‐up study
AP Groenman, J Oosterlaan, N Rommelse, B Franke, H Roeyers, ...
Addiction 108 (8), 1503-1511, 2013
1652013
Childhood Psychiatric Disorders as Risk Factor for Subsequent Substance Abuse: A Meta-Analysis
AP Groenman, TWP Janssen, J Oosterlaan
Journal of the American Academy of Child & Adolescent Psychiatry, 2017
1602017
The NeuroIMAGE study: a prospective phenotypic, cognitive, genetic and MRI study in children with attention-deficit/hyperactivity disorder. Design and descriptives
D von Rhein, M Mennes, H van Ewijk, AP Groenman, MP Zwiers, ...
European child & adolescent psychiatry 24 (3), 265-281, 2015
1482015
A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood
M van Lieshout, M Luman, JWR Twisk, H van Ewijk, AP Groenman, ...
European child & adolescent psychiatry 25 (9), 1007-1017, 2016
1032016
Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder
AP Groenman, J Oosterlaan, NNJ Rommelse, B Franke, CU Greven, ...
The British Journal of Psychiatry 203 (2), 112-119, 2013
852013
An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder
AP Groenman, LJS Schweren, A Dietrich, PJ Hoekstra
Expert opinion on drug safety 16 (4), 455-464, 2017
452017
Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4‐year prospective follow‐up
AP Groenman, J Oosterlaan, CU Greven, PJ Vuijk, N Rommelse, ...
Journal of Child Psychology and Psychiatry 56 (5), 521-529, 2015
242015
Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder
AP Groenman, LJS Schweren, W Weeda, M Luman, SDS Noordermeer, ...
European child & adolescent psychiatry 28 (9), 1213-1222, 2019
202019
Smoking and the developing brain: altered white matter microstructure in attention‐deficit/hyperactivity disorder and healthy controls
H van Ewijk*, AP Groenman*, MP Zwiers, DJ Heslenfeld, SV Faraone, ...
Human Brain Mapping 36 (3), 1180-1189, 2015
202015
Substance use and nicotine dependence in persistent, remittent, and late-onset ADHD: a 10-year longitudinal study from childhood to young adulthood
S Ilbegi, AP Groenman, A Schellekens, CA Hartman, PJ Hoekstra, ...
Journal of neurodevelopmental disorders 10 (1), 1-8, 2018
182018
Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder
AP Groenman, CU Greven, MMJ Van Donkelaar, A Schellekens, ...
Addiction biology 21 (4), 915-923, 2016
172016
International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder and substance use disorder
H Özgen, R Spijkerman, M Noack, M Holtmann, ASA Schellekens, ...
European addiction research 26 (4-5), 223-232, 2020
132020
Stimulant treatment trajectories are associated with neural reward processing in attention-deficit/hyperactivity disorder
LJS Schweren, A Groenman, D von Rhein, W Weeda, SF Faraone, ...
The Journal of clinical psychiatry 78 (7), 0-0, 2017
112017
Age and DRD4 genotype moderate associations between stimulant treatment history and cortex structure in attention-deficit/hyperactivity disorder
LJS Schweren, CA Hartman, DJ Heslenfeld, AP Groenman, B Franke, ...
Journal of the American Academy of Child & Adolescent Psychiatry 55 (10 …, 2016
102016
Role of conduct problems in the relation between Attention-Deficit Hyperactivity disorder, substance use, and gaming
GH Schoenmacker, AP Groenman, E Sokolova, J Oosterlaan, ...
European Neuropsychopharmacology 30, 102-113, 2020
72020
Ageing and heterogeneity regarding autism spectrum conditions: a protocol paper of an accelerated longitudinal study
HM Geurts, JAA van Rentergem, T Radhoe, C Torenvliet, ...
BMJ open 11 (3), e040943, 2021
32021
Assessing quality of life in psychosocial and mental health disorders in children: a comprehensive overview and appraisal of generic health related quality of life measures
JO Mierau, D Kann-Weedage, PJ Hoekstra, L Spiegelaar, DEMC Jansen, ...
BMC pediatrics 20 (1), 1-16, 2020
22020
Non‐pharmacological interventions for challenging behaviours of adults with intellectual disabilities: A meta‐analysis
E Bruinsma, BJ van den Hoofdakker, AP Groenman, PJ Hoekstra, ...
Journal of Intellectual Disability Research 64 (8), 561-578, 2020
22020
Menstruation and Menopause in autistic adults: Periods of importance?
A Groenman, C Torenvliet, T Radhoe, JA van Rentergem, H Geurts
PsyArXiv, 2021
12021
Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD
HGH Tamminga, L Reneman, A Schrantee, MA Bottelier, C Bouziane, ...
European Neuropsychopharmacology 46, 1-13, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20